Refractory anemia with excess of blasts
| Refractory anemia with excess of blasts | |
|---|---|
| Specialty | Oncology  |
Refractory anemia with excess of blasts (RAEB) is a type of myelodysplastic syndrome[1] with a marrow blast percentage of 5% to 19%.[2]
In MeSH, "Smoldering leukemia" is classified under RAEB.[3]
References
- ^ Palmieri S, D'Arco AM, Celentano M; et al. (2006). "An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients". Ann. Oncol. 17 (7): 1146–51. doi:10.1093/annonc/mdl083. PMID 16687417.
{{cite journal}}: Explicit use of et al. in:|author=(help); Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M (1997). "Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy". Blood. 90 (8): 2969–77. PMID 9376577.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - ^ Leukemia,+Smoldering at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
External links
- Smoldering leukemia entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.
 | This medical article is a stub. You can help Wikipedia by expanding it. |